Varmus vs. Daschle vs. Dean?

Now that election day is over and we can stop feverishly predicting who will move into the White House, it's time to start feverishly predicting who President-elect Barack Obama will appoint to linkurl:key positions;http://www.the-scientist.com/blog/display/55167/ in his cabinet. So far, the linkurl:Wall Street Journal;http://blogs.wsj.com/washwire/2008/11/05/horse-race-begins-for-new-leaders-at-fda-and-hhs/ has heard three names as potential leaders of the Health and Human Services: linkurl:Ha

Written byAlison McCook
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Now that election day is over and we can stop feverishly predicting who will move into the White House, it's time to start feverishly predicting who President-elect Barack Obama will appoint to linkurl:key positions;http://www.the-scientist.com/blog/display/55167/ in his cabinet. So far, the linkurl:Wall Street Journal;http://blogs.wsj.com/washwire/2008/11/05/horse-race-begins-for-new-leaders-at-fda-and-hhs/ has heard three names as potential leaders of the Health and Human Services: linkurl:Harold Varmus,;http://www.the-scientist.com/article/display/23543/ former Senator linkurl:Tom Daschle,;http://www.the-scientist.com/article/display/22134/ and Howard Dean, a doctor and Democratic National Committee chairman. For the FDA, the WSJ predicts the commissioner's position could go to linkurl:Steven Nissen,;http://www.the-scientist.com/news/display/24056/ a critic of industry ties to the agency who has been advising Obama. Other names the journal has heard bandied about for FDA chief include Mike Taylor (Dep. Commissioner under Clinton), Robert Califf at Duke, Mary Pendergast, and linkurl:Janet Woodcock,;http://www.the-scientist.com/article/display/53306/ head of FDA's Center for Drug Evaluation and Research. Who do you think could (or should) take over these posts?
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies